Aurora Cannabis Inc (ACB): Next-Year EPS Estimate 135.86%
As of 2026-11-12, Aurora Cannabis Inc (ACB) has a next-year EPS growth estimate of 135.86%. Featured in 4 EPS revision reports, most recently on 2026-08-17.
On 2026-11-11, analyst consensus for ACB's next-year EPS growth shifted from 120.85% to 135.86% — a positive change of 15.01 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at 62.07%.
What's Driving This
ACB stock has been rising primarily because analysts sharply
Generated 2026-10-09 from news as of 2026-10-09
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 135.86%
- EPS growth this year
- 62.07%
- EPS next quarter (est)
- -$0.06
- Last price
- $4.99
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 135.86% | 62.07% | -$0.06 | $4.99 |
| 2026-11-11 | 135.86% | 62.07% | -$0.06 | $5.05 |
| 2026-11-10 | 120.85% | 65.84% | -$0.06 | $5.11 |
| 2026-11-09 | 120.85% | 65.84% | -$0.06 | $5.16 |
| 2026-11-07 | 119.63% | 70.76% | -$0.06 | $5.24 |
| 2026-11-06 | 119.63% | 70.76% | -$0.06 | $5.24 |
| 2026-11-05 | 150.30% | 85.11% | -$0.02 | $5.19 |
| 2026-11-04 | 161.07% | 86.26% | -$0.05 | $5.24 |
| 2026-11-03 | 161.44% | 86.29% | -$0.05 | $5.16 |
| 2026-11-02 | 161.44% | 86.29% | -$0.05 | $4.22 |
| 2026-10-31 | 161.44% | 86.29% | -$0.05 | $4.06 |
| 2026-10-30 | 161.44% | 86.29% | -$0.05 | $4.06 |
| 2026-10-29 | 161.44% | 86.29% | -$0.05 | $4.08 |
| 2026-10-28 | 161.44% | 86.29% | -$0.05 | $4.08 |
| 2026-10-27 | 161.44% | 86.29% | -$0.05 | $4.15 |
| 2026-10-26 | 161.44% | 86.29% | -$0.05 | $3.90 |
| 2026-10-23 | 161.44% | 86.29% | -$0.05 | $3.88 |
| 2026-10-22 | 161.44% | 86.29% | -$0.05 | $3.97 |
| 2026-10-21 | 161.44% | 86.29% | -$0.05 | $3.96 |
| 2026-10-20 | 161.44% | 86.29% | -$0.05 | $3.97 |
| 2026-10-19 | 161.44% | 86.29% | -$0.05 | $3.96 |
| 2026-10-16 | 161.44% | 86.29% | -$0.05 | $3.99 |
| 2026-10-15 | 161.44% | 86.29% | -$0.05 | $4.10 |
| 2026-10-14 | 161.44% | 86.29% | -$0.05 | $4.17 |
| 2026-10-13 | 161.44% | 86.29% | -$0.05 | $4.29 |
| 2026-10-12 | 161.68% | 86.29% | -$0.05 | $4.35 |
| 2026-10-11 | 161.68% | 86.29% | -$0.05 | $4.49 |
| 2026-10-10 | 161.68% | 86.29% | -$0.05 | $4.49 |
| 2026-10-09 | 161.68% | 86.29% | -$0.05 | $4.49 |
| 2026-10-08 | 161.68% | 86.29% | -$0.05 | $4.43 |
Reports Featuring ACB
- 2026-08-17
SNDK Soars 45.9% After EPS Revision, AI Memory Boom Fuels Rally
- 2026-08-14
SHAZ Soars 53.6% on AI Capacity Surge; SNDK, ACB Rally on EPS Revisions
- 2026-08-13
SHAZ Surges 44.6% on AI Capacity Expansion; SNDK, ACB, CLMT, NYXH Follow
- 2026-08-12
SHAZ Soars 37.5% as AI Capacity Surges; Top EPS Revision Gainers
Recent News
- Aurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis MarketPR Newswire
- AURORA CANNABIS INC. URGES SHAREHOLDERS TO TAKE NO ACTION AT THIS TIME IN RESPECT TO THE UNSOLICITED TAKE-OVER BID BY CURALEAF HOLDINGS, INC.PR Newswire
- Curaleaf CEO talks unsolicited offer to buy Aurora CannabisCNBC TV
- Why Aurora Cannabis Looks Cheaper Than Its International Growth Suggests Quarterly Update ReportExec Edge
- Why Aurora Cannabis Looks Cheaper Than Its International Growth Suggests Downloadable Quarterly Update ReportExec Edge
- Safari Flower Company, a Wholly Owned Subsidiary of Aurora Cannabis, Receives EU-GMP Certification at Niagara FacilityPR Newswire
- Aurora Cannabis Inc (ACB) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...GuruFocus.com
- Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results with Record Annual Revenue and Adjusted EBITDA¹PR Newswire
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Aurora Cannabis Inc's next-year EPS growth estimate?▾
As of 2026-11-12, Aurora Cannabis Inc (ACB) has a next-year EPS growth estimate of 135.86%, based on analyst consensus.
When was the latest EPS estimate revision for ACB?▾
The most recent revision occurred on 2026-11-11, when analysts adjusted the next-year EPS growth estimate from 120.85% to 135.86%.
What sector and industry does Aurora Cannabis Inc belong to?▾
Aurora Cannabis Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ACB appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Aurora Cannabis Inc (ACB) appears here because it was detected by our daily top-EPS-revision-performer screen.